Trial Profile
A Phase II Evaluation of Metformin, Targeting Cancer Stem Cells for the Prevention of Relapse in Patients With Stage IIC/III/IV Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Antineoplastics
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 24 May 2018 Status changed from active, no longer recruiting to completed.
- 03 Jul 2017 Planned End Date changed from 1 Oct 2016 to 1 Feb 2018.
- 03 Jul 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Feb 2018.